Solid Biosciences

Solid Biosciences

Advance the development of its novel gene therapy platform.

Launch date
Employees
Market cap
€271m
Enterprise valuation
€121m (Public information from Sep 2024)
Boston Massachusetts (HQ)
Authorizing premium user...